nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Rash—Fulvestrant—breast cancer	0.0034	0.00343	CcSEcCtD
Emedastine—Dermatitis—Fulvestrant—breast cancer	0.0034	0.00343	CcSEcCtD
Emedastine—Headache—Fulvestrant—breast cancer	0.00338	0.00341	CcSEcCtD
Emedastine—Pain—Raloxifene—breast cancer	0.00338	0.00341	CcSEcCtD
Emedastine—Asthenia—Exemestane—breast cancer	0.00336	0.00339	CcSEcCtD
Emedastine—Rash—Toremifene—breast cancer	0.00336	0.00339	CcSEcCtD
Emedastine—Mental disorder—Goserelin—breast cancer	0.00336	0.00339	CcSEcCtD
Emedastine—Dermatitis—Toremifene—breast cancer	0.00335	0.00339	CcSEcCtD
Emedastine—Headache—Toremifene—breast cancer	0.00334	0.00337	CcSEcCtD
Emedastine—Pruritus—Exemestane—breast cancer	0.00332	0.00335	CcSEcCtD
Emedastine—Stinging—Epirubicin—breast cancer	0.00324	0.00327	CcSEcCtD
Emedastine—Cardiac disorder—Vinorelbine—breast cancer	0.00318	0.00321	CcSEcCtD
Emedastine—Asthenia—Ixabepilone—breast cancer	0.00317	0.0032	CcSEcCtD
Emedastine—Vision blurred—Goserelin—breast cancer	0.00314	0.00317	CcSEcCtD
Emedastine—Pruritus—Ixabepilone—breast cancer	0.00313	0.00316	CcSEcCtD
Emedastine—Eye disorder—Thiotepa—breast cancer	0.00306	0.00309	CcSEcCtD
Emedastine—Cardiac disorder—Thiotepa—breast cancer	0.00304	0.00307	CcSEcCtD
Emedastine—Eye pain—Capecitabine—breast cancer	0.00303	0.00306	CcSEcCtD
Emedastine—Discomfort—Vinblastine—breast cancer	0.00302	0.00305	CcSEcCtD
Emedastine—Stinging—Doxorubicin—breast cancer	0.003	0.00303	CcSEcCtD
Emedastine—Asthenia—Letrozole—breast cancer	0.00299	0.00302	CcSEcCtD
Emedastine—Asthenia—Anastrozole—breast cancer	0.00299	0.00302	CcSEcCtD
Emedastine—Sinusitis—Mitoxantrone—breast cancer	0.00296	0.00298	CcSEcCtD
Emedastine—Rash—Exemestane—breast cancer	0.00296	0.00298	CcSEcCtD
Emedastine—Dermatitis—Exemestane—breast cancer	0.00295	0.00298	CcSEcCtD
Emedastine—Pruritus—Letrozole—breast cancer	0.00295	0.00297	CcSEcCtD
Emedastine—Pruritus—Anastrozole—breast cancer	0.00295	0.00297	CcSEcCtD
Emedastine—Discomfort—Tamoxifen—breast cancer	0.00294	0.00296	CcSEcCtD
Emedastine—Headache—Exemestane—breast cancer	0.00294	0.00296	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—breast cancer	0.00289	0.00292	CcSEcCtD
Emedastine—Mental disorder—Thiotepa—breast cancer	0.00287	0.0029	CcSEcCtD
Emedastine—Lacrimation increased—Epirubicin—breast cancer	0.00285	0.00288	CcSEcCtD
Emedastine—Rhinitis—Irinotecan—breast cancer	0.00284	0.00286	CcSEcCtD
Emedastine—Rhinitis—Mitoxantrone—breast cancer	0.00284	0.00286	CcSEcCtD
Emedastine—Sinusitis—Fluorouracil—breast cancer	0.00283	0.00286	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Goserelin—breast cancer	0.00282	0.00285	CcSEcCtD
Emedastine—Discomfort—Goserelin—breast cancer	0.00281	0.00283	CcSEcCtD
Emedastine—Rash—Ixabepilone—breast cancer	0.00279	0.00281	CcSEcCtD
Emedastine—Dermatitis—Ixabepilone—breast cancer	0.00279	0.00281	CcSEcCtD
Emedastine—Headache—Ixabepilone—breast cancer	0.00277	0.0028	CcSEcCtD
Emedastine—Rhinitis—Gemcitabine—breast cancer	0.00276	0.00279	CcSEcCtD
Emedastine—Pain—Chlorambucil—breast cancer	0.00274	0.00276	CcSEcCtD
Emedastine—Tachycardia—Melphalan—breast cancer	0.00272	0.00275	CcSEcCtD
Emedastine—Olanzapine—CYP2D6—breast cancer	0.00272	0.301	CrCbGaD
Emedastine—Rhinitis—Fluorouracil—breast cancer	0.00272	0.00274	CcSEcCtD
Emedastine—Skin disorder—Melphalan—breast cancer	0.00271	0.00274	CcSEcCtD
Emedastine—Vision blurred—Thiotepa—breast cancer	0.00269	0.00271	CcSEcCtD
Emedastine—Nervous system disorder—Goserelin—breast cancer	0.00267	0.00269	CcSEcCtD
Emedastine—Tachycardia—Goserelin—breast cancer	0.00266	0.00268	CcSEcCtD
Emedastine—Skin disorder—Goserelin—breast cancer	0.00264	0.00267	CcSEcCtD
Emedastine—Lacrimation increased—Doxorubicin—breast cancer	0.00264	0.00266	CcSEcCtD
Emedastine—Cardiac disorder—Irinotecan—breast cancer	0.00263	0.00265	CcSEcCtD
Emedastine—Rash—Anastrozole—breast cancer	0.00263	0.00265	CcSEcCtD
Emedastine—Rash—Letrozole—breast cancer	0.00263	0.00265	CcSEcCtD
Emedastine—Dermatitis—Letrozole—breast cancer	0.00262	0.00265	CcSEcCtD
Emedastine—Dermatitis—Anastrozole—breast cancer	0.00262	0.00265	CcSEcCtD
Emedastine—Headache—Anastrozole—breast cancer	0.00261	0.00263	CcSEcCtD
Emedastine—Headache—Letrozole—breast cancer	0.00261	0.00263	CcSEcCtD
Emedastine—Abnormal dreams—Epirubicin—breast cancer	0.0026	0.00262	CcSEcCtD
Emedastine—Cardiac disorder—Gemcitabine—breast cancer	0.00256	0.00258	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—breast cancer	0.00253	0.00255	CcSEcCtD
Emedastine—Discomfort—Vinorelbine—breast cancer	0.00251	0.00254	CcSEcCtD
Emedastine—Pain—Vinblastine—breast cancer	0.00251	0.00253	CcSEcCtD
Emedastine—Rash—Raloxifene—breast cancer	0.00249	0.00251	CcSEcCtD
Emedastine—Rash—Idarubicin—breast cancer	0.00249	0.00251	CcSEcCtD
Emedastine—Dermatitis—Raloxifene—breast cancer	0.00249	0.00251	CcSEcCtD
Emedastine—Dermatitis—Idarubicin—breast cancer	0.00249	0.00251	CcSEcCtD
Emedastine—Headache—Raloxifene—breast cancer	0.00248	0.0025	CcSEcCtD
Emedastine—Headache—Idarubicin—breast cancer	0.00248	0.0025	CcSEcCtD
Emedastine—Pain—Tamoxifen—breast cancer	0.00244	0.00246	CcSEcCtD
Emedastine—Dry eye—Epirubicin—breast cancer	0.00243	0.00245	CcSEcCtD
Emedastine—Dysgeusia—Mitoxantrone—breast cancer	0.00241	0.00243	CcSEcCtD
Emedastine—Sinusitis—Paclitaxel—breast cancer	0.00241	0.00243	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—breast cancer	0.00241	0.00243	CcSEcCtD
Emedastine—Abnormal dreams—Doxorubicin—breast cancer	0.0024	0.00242	CcSEcCtD
Emedastine—Nervous system disorder—Vinorelbine—breast cancer	0.00239	0.00241	CcSEcCtD
Emedastine—Pain—Melphalan—breast cancer	0.00239	0.00241	CcSEcCtD
Emedastine—Tachycardia—Vinorelbine—breast cancer	0.00238	0.0024	CcSEcCtD
Emedastine—Skin disorder—Vinorelbine—breast cancer	0.00237	0.00239	CcSEcCtD
Emedastine—Olanzapine—CYP3A4—breast cancer	0.00233	0.258	CrCbGaD
Emedastine—Pain—Goserelin—breast cancer	0.00233	0.00235	CcSEcCtD
Emedastine—Vision blurred—Mitoxantrone—breast cancer	0.00232	0.00234	CcSEcCtD
Emedastine—Rhinitis—Paclitaxel—breast cancer	0.00231	0.00233	CcSEcCtD
Emedastine—Asthenia—Chlorambucil—breast cancer	0.0023	0.00232	CcSEcCtD
Emedastine—Nervous system disorder—Thiotepa—breast cancer	0.00228	0.0023	CcSEcCtD
Emedastine—Tachycardia—Thiotepa—breast cancer	0.00227	0.00229	CcSEcCtD
Emedastine—Pruritus—Chlorambucil—breast cancer	0.00226	0.00229	CcSEcCtD
Emedastine—Skin disorder—Thiotepa—breast cancer	0.00226	0.00228	CcSEcCtD
Emedastine—Dry eye—Doxorubicin—breast cancer	0.00225	0.00227	CcSEcCtD
Emedastine—Vision blurred—Fluorouracil—breast cancer	0.00222	0.00224	CcSEcCtD
Emedastine—Eye disorder—Paclitaxel—breast cancer	0.00216	0.00218	CcSEcCtD
Emedastine—Cardiac disorder—Paclitaxel—breast cancer	0.00214	0.00216	CcSEcCtD
Emedastine—Eye pain—Epirubicin—breast cancer	0.00211	0.00213	CcSEcCtD
Emedastine—Asthenia—Vinblastine—breast cancer	0.0021	0.00212	CcSEcCtD
Emedastine—Pain—Vinorelbine—breast cancer	0.00208	0.0021	CcSEcCtD
Emedastine—Discomfort—Irinotecan—breast cancer	0.00207	0.00209	CcSEcCtD
Emedastine—Discomfort—Mitoxantrone—breast cancer	0.00207	0.00209	CcSEcCtD
Emedastine—Asthenia—Tamoxifen—breast cancer	0.00204	0.00206	CcSEcCtD
Emedastine—Olanzapine—ALB—breast cancer	0.00204	0.225	CrCbGaD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.00203	0.00205	CcSEcCtD
Emedastine—Mental disorder—Paclitaxel—breast cancer	0.00202	0.00204	CcSEcCtD
Emedastine—Discomfort—Gemcitabine—breast cancer	0.00202	0.00204	CcSEcCtD
Emedastine—Pruritus—Tamoxifen—breast cancer	0.00202	0.00203	CcSEcCtD
Emedastine—Asthenia—Melphalan—breast cancer	0.002	0.00202	CcSEcCtD
Emedastine—Pain—Thiotepa—breast cancer	0.00199	0.00201	CcSEcCtD
Emedastine—Discomfort—Fluorouracil—breast cancer	0.00198	0.002	CcSEcCtD
Emedastine—Pruritus—Melphalan—breast cancer	0.00197	0.00199	CcSEcCtD
Emedastine—Nervous system disorder—Irinotecan—breast cancer	0.00197	0.00199	CcSEcCtD
Emedastine—Dysgeusia—Paclitaxel—breast cancer	0.00197	0.00199	CcSEcCtD
Emedastine—Tachycardia—Mitoxantrone—breast cancer	0.00196	0.00198	CcSEcCtD
Emedastine—Rhinitis—Docetaxel—breast cancer	0.00196	0.00198	CcSEcCtD
Emedastine—Eye pain—Doxorubicin—breast cancer	0.00195	0.00197	CcSEcCtD
Emedastine—Asthenia—Goserelin—breast cancer	0.00195	0.00197	CcSEcCtD
Emedastine—Skin disorder—Mitoxantrone—breast cancer	0.00195	0.00197	CcSEcCtD
Emedastine—Olanzapine—ABCB1—breast cancer	0.00194	0.215	CrCbGaD
Emedastine—Pruritus—Goserelin—breast cancer	0.00193	0.00194	CcSEcCtD
Emedastine—Nervous system disorder—Gemcitabine—breast cancer	0.00192	0.00194	CcSEcCtD
Emedastine—Skin disorder—Gemcitabine—breast cancer	0.0019	0.00192	CcSEcCtD
Emedastine—Rhinitis—Capecitabine—breast cancer	0.0019	0.00192	CcSEcCtD
Emedastine—Vision blurred—Paclitaxel—breast cancer	0.00189	0.00191	CcSEcCtD
Emedastine—Nervous system disorder—Fluorouracil—breast cancer	0.00189	0.00191	CcSEcCtD
Emedastine—Tachycardia—Fluorouracil—breast cancer	0.00188	0.0019	CcSEcCtD
Emedastine—Headache—Vinblastine—breast cancer	0.00184	0.00185	CcSEcCtD
Emedastine—Eye disorder—Docetaxel—breast cancer	0.00183	0.00184	CcSEcCtD
Emedastine—Cardiac disorder—Docetaxel—breast cancer	0.00182	0.00183	CcSEcCtD
Emedastine—Rash—Tamoxifen—breast cancer	0.0018	0.00181	CcSEcCtD
Emedastine—Dermatitis—Tamoxifen—breast cancer	0.0018	0.00181	CcSEcCtD
Emedastine—Headache—Tamoxifen—breast cancer	0.00179	0.0018	CcSEcCtD
Emedastine—Eye disorder—Capecitabine—breast cancer	0.00177	0.00179	CcSEcCtD
Emedastine—Rash—Melphalan—breast cancer	0.00176	0.00178	CcSEcCtD
Emedastine—Cardiac disorder—Capecitabine—breast cancer	0.00176	0.00177	CcSEcCtD
Emedastine—Dermatitis—Melphalan—breast cancer	0.00176	0.00177	CcSEcCtD
Emedastine—Asthenia—Vinorelbine—breast cancer	0.00175	0.00177	CcSEcCtD
Emedastine—Pruritus—Vinorelbine—breast cancer	0.00172	0.00174	CcSEcCtD
Emedastine—Pain—Mitoxantrone—breast cancer	0.00172	0.00173	CcSEcCtD
Emedastine—Pain—Irinotecan—breast cancer	0.00172	0.00173	CcSEcCtD
Emedastine—Rash—Goserelin—breast cancer	0.00172	0.00173	CcSEcCtD
Emedastine—Dermatitis—Goserelin—breast cancer	0.00171	0.00173	CcSEcCtD
Emedastine—Mental disorder—Docetaxel—breast cancer	0.00171	0.00173	CcSEcCtD
Emedastine—Headache—Goserelin—breast cancer	0.00171	0.00172	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.0017	0.00171	CcSEcCtD
Emedastine—Discomfort—Paclitaxel—breast cancer	0.00169	0.00171	CcSEcCtD
Emedastine—Pain—Gemcitabine—breast cancer	0.00167	0.00169	CcSEcCtD
Emedastine—Asthenia—Thiotepa—breast cancer	0.00167	0.00169	CcSEcCtD
Emedastine—Dysgeusia—Docetaxel—breast cancer	0.00167	0.00168	CcSEcCtD
Emedastine—Mental disorder—Capecitabine—breast cancer	0.00166	0.00167	CcSEcCtD
Emedastine—Pruritus—Thiotepa—breast cancer	0.00165	0.00166	CcSEcCtD
Emedastine—Pain—Fluorouracil—breast cancer	0.00165	0.00166	CcSEcCtD
Emedastine—Dysgeusia—Capecitabine—breast cancer	0.00161	0.00163	CcSEcCtD
Emedastine—Nervous system disorder—Paclitaxel—breast cancer	0.00161	0.00162	CcSEcCtD
Emedastine—Tachycardia—Paclitaxel—breast cancer	0.0016	0.00161	CcSEcCtD
Emedastine—Skin disorder—Paclitaxel—breast cancer	0.00159	0.00161	CcSEcCtD
Emedastine—Vision blurred—Capecitabine—breast cancer	0.00155	0.00157	CcSEcCtD
Emedastine—Rash—Vinorelbine—breast cancer	0.00154	0.00155	CcSEcCtD
Emedastine—Dermatitis—Vinorelbine—breast cancer	0.00154	0.00155	CcSEcCtD
Emedastine—Headache—Vinorelbine—breast cancer	0.00153	0.00154	CcSEcCtD
Emedastine—Rash—Thiotepa—breast cancer	0.00147	0.00148	CcSEcCtD
Emedastine—Dermatitis—Thiotepa—breast cancer	0.00147	0.00148	CcSEcCtD
Emedastine—Headache—Thiotepa—breast cancer	0.00146	0.00147	CcSEcCtD
Emedastine—Asthenia—Irinotecan—breast cancer	0.00144	0.00146	CcSEcCtD
Emedastine—Asthenia—Mitoxantrone—breast cancer	0.00144	0.00146	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.00144	0.00145	CcSEcCtD
Emedastine—Asthenia—Gemcitabine—breast cancer	0.00141	0.00142	CcSEcCtD
Emedastine—Pain—Paclitaxel—breast cancer	0.0014	0.00141	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.00139	0.00141	CcSEcCtD
Emedastine—Discomfort—Capecitabine—breast cancer	0.00139	0.0014	CcSEcCtD
Emedastine—Pruritus—Gemcitabine—breast cancer	0.00139	0.0014	CcSEcCtD
Emedastine—Sinusitis—Epirubicin—breast cancer	0.00138	0.00139	CcSEcCtD
Emedastine—Nervous system disorder—Docetaxel—breast cancer	0.00136	0.00138	CcSEcCtD
Emedastine—Pruritus—Fluorouracil—breast cancer	0.00136	0.00137	CcSEcCtD
Emedastine—Tachycardia—Docetaxel—breast cancer	0.00136	0.00137	CcSEcCtD
Emedastine—Skin disorder—Docetaxel—breast cancer	0.00135	0.00136	CcSEcCtD
Emedastine—Rhinitis—Epirubicin—breast cancer	0.00132	0.00133	CcSEcCtD
Emedastine—Nervous system disorder—Capecitabine—breast cancer	0.00132	0.00133	CcSEcCtD
Emedastine—Eye disorder—Methotrexate—breast cancer	0.00132	0.00133	CcSEcCtD
Emedastine—Tachycardia—Capecitabine—breast cancer	0.00131	0.00133	CcSEcCtD
Emedastine—Cardiac disorder—Methotrexate—breast cancer	0.00131	0.00132	CcSEcCtD
Emedastine—Skin disorder—Capecitabine—breast cancer	0.00131	0.00132	CcSEcCtD
Emedastine—Sinusitis—Doxorubicin—breast cancer	0.00128	0.00129	CcSEcCtD
Emedastine—Rash—Mitoxantrone—breast cancer	0.00127	0.00128	CcSEcCtD
Emedastine—Rash—Irinotecan—breast cancer	0.00127	0.00128	CcSEcCtD
Emedastine—Dermatitis—Irinotecan—breast cancer	0.00127	0.00128	CcSEcCtD
Emedastine—Dermatitis—Mitoxantrone—breast cancer	0.00127	0.00128	CcSEcCtD
Emedastine—Headache—Mitoxantrone—breast cancer	0.00126	0.00127	CcSEcCtD
Emedastine—Headache—Irinotecan—breast cancer	0.00126	0.00127	CcSEcCtD
Emedastine—Mental disorder—Methotrexate—breast cancer	0.00124	0.00125	CcSEcCtD
Emedastine—Rash—Gemcitabine—breast cancer	0.00123	0.00125	CcSEcCtD
Emedastine—Dermatitis—Gemcitabine—breast cancer	0.00123	0.00124	CcSEcCtD
Emedastine—Eye disorder—Epirubicin—breast cancer	0.00123	0.00124	CcSEcCtD
Emedastine—Headache—Gemcitabine—breast cancer	0.00123	0.00124	CcSEcCtD
Emedastine—Cardiac disorder—Epirubicin—breast cancer	0.00122	0.00124	CcSEcCtD
Emedastine—Rhinitis—Doxorubicin—breast cancer	0.00122	0.00124	CcSEcCtD
Emedastine—Rash—Fluorouracil—breast cancer	0.00121	0.00123	CcSEcCtD
Emedastine—Dermatitis—Fluorouracil—breast cancer	0.00121	0.00122	CcSEcCtD
Emedastine—Headache—Fluorouracil—breast cancer	0.00121	0.00122	CcSEcCtD
Emedastine—Dysgeusia—Methotrexate—breast cancer	0.0012	0.00121	CcSEcCtD
Emedastine—Pain—Docetaxel—breast cancer	0.00119	0.0012	CcSEcCtD
Emedastine—Asthenia—Paclitaxel—breast cancer	0.00118	0.00119	CcSEcCtD
Emedastine—Pruritus—Paclitaxel—breast cancer	0.00116	0.00117	CcSEcCtD
Emedastine—Vision blurred—Methotrexate—breast cancer	0.00116	0.00117	CcSEcCtD
Emedastine—Mental disorder—Epirubicin—breast cancer	0.00116	0.00117	CcSEcCtD
Emedastine—Pain—Capecitabine—breast cancer	0.00115	0.00116	CcSEcCtD
Emedastine—Eye disorder—Doxorubicin—breast cancer	0.00114	0.00115	CcSEcCtD
Emedastine—Cardiac disorder—Doxorubicin—breast cancer	0.00113	0.00114	CcSEcCtD
Emedastine—Dysgeusia—Epirubicin—breast cancer	0.00112	0.00114	CcSEcCtD
Emedastine—Vision blurred—Epirubicin—breast cancer	0.00108	0.00109	CcSEcCtD
Emedastine—Mental disorder—Doxorubicin—breast cancer	0.00107	0.00108	CcSEcCtD
Emedastine—Dysgeusia—Doxorubicin—breast cancer	0.00104	0.00105	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.00104	0.00105	CcSEcCtD
Emedastine—Rash—Paclitaxel—breast cancer	0.00103	0.00104	CcSEcCtD
Emedastine—Dermatitis—Paclitaxel—breast cancer	0.00103	0.00104	CcSEcCtD
Emedastine—Discomfort—Methotrexate—breast cancer	0.00103	0.00104	CcSEcCtD
Emedastine—Headache—Paclitaxel—breast cancer	0.00103	0.00104	CcSEcCtD
Emedastine—Vision blurred—Doxorubicin—breast cancer	0.001	0.00101	CcSEcCtD
Emedastine—Asthenia—Docetaxel—breast cancer	0.000997	0.00101	CcSEcCtD
Emedastine—Pruritus—Docetaxel—breast cancer	0.000983	0.000992	CcSEcCtD
Emedastine—Nervous system disorder—Methotrexate—breast cancer	0.000982	0.000991	CcSEcCtD
Emedastine—Skin disorder—Methotrexate—breast cancer	0.000973	0.000982	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000971	0.00098	CcSEcCtD
Emedastine—Discomfort—Epirubicin—breast cancer	0.000966	0.000975	CcSEcCtD
Emedastine—Asthenia—Capecitabine—breast cancer	0.000965	0.000974	CcSEcCtD
Emedastine—Pruritus—Capecitabine—breast cancer	0.000952	0.000961	CcSEcCtD
Emedastine—Nervous system disorder—Epirubicin—breast cancer	0.000919	0.000928	CcSEcCtD
Emedastine—Tachycardia—Epirubicin—breast cancer	0.000915	0.000923	CcSEcCtD
Emedastine—Skin disorder—Epirubicin—breast cancer	0.000911	0.000919	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000899	0.000907	CcSEcCtD
Emedastine—Discomfort—Doxorubicin—breast cancer	0.000894	0.000902	CcSEcCtD
Emedastine—Rash—Docetaxel—breast cancer	0.000876	0.000884	CcSEcCtD
Emedastine—Dermatitis—Docetaxel—breast cancer	0.000876	0.000883	CcSEcCtD
Emedastine—Headache—Docetaxel—breast cancer	0.000871	0.000879	CcSEcCtD
Emedastine—Pain—Methotrexate—breast cancer	0.000857	0.000864	CcSEcCtD
Emedastine—Nervous system disorder—Doxorubicin—breast cancer	0.000851	0.000858	CcSEcCtD
Emedastine—Rash—Capecitabine—breast cancer	0.000848	0.000856	CcSEcCtD
Emedastine—Dermatitis—Capecitabine—breast cancer	0.000848	0.000855	CcSEcCtD
Emedastine—Tachycardia—Doxorubicin—breast cancer	0.000847	0.000854	CcSEcCtD
Emedastine—Headache—Capecitabine—breast cancer	0.000843	0.000851	CcSEcCtD
Emedastine—Skin disorder—Doxorubicin—breast cancer	0.000843	0.00085	CcSEcCtD
Emedastine—Pain—Epirubicin—breast cancer	0.000802	0.000809	CcSEcCtD
Emedastine—Pain—Doxorubicin—breast cancer	0.000742	0.000749	CcSEcCtD
Emedastine—Asthenia—Methotrexate—breast cancer	0.000719	0.000725	CcSEcCtD
Emedastine—Pruritus—Methotrexate—breast cancer	0.000709	0.000715	CcSEcCtD
Emedastine—Asthenia—Epirubicin—breast cancer	0.000673	0.000679	CcSEcCtD
Emedastine—Pruritus—Epirubicin—breast cancer	0.000663	0.000669	CcSEcCtD
Emedastine—Rash—Methotrexate—breast cancer	0.000632	0.000637	CcSEcCtD
Emedastine—Dermatitis—Methotrexate—breast cancer	0.000631	0.000637	CcSEcCtD
Emedastine—Headache—Methotrexate—breast cancer	0.000628	0.000633	CcSEcCtD
Emedastine—Asthenia—Doxorubicin—breast cancer	0.000622	0.000628	CcSEcCtD
Emedastine—Pruritus—Doxorubicin—breast cancer	0.000614	0.000619	CcSEcCtD
Emedastine—Rash—Epirubicin—breast cancer	0.000591	0.000596	CcSEcCtD
Emedastine—Dermatitis—Epirubicin—breast cancer	0.000591	0.000596	CcSEcCtD
Emedastine—Headache—Epirubicin—breast cancer	0.000587	0.000593	CcSEcCtD
Emedastine—Rash—Doxorubicin—breast cancer	0.000547	0.000552	CcSEcCtD
Emedastine—Dermatitis—Doxorubicin—breast cancer	0.000546	0.000551	CcSEcCtD
Emedastine—Headache—Doxorubicin—breast cancer	0.000543	0.000548	CcSEcCtD
